"C\u00EDl: Posoudit vlastn\u00ED zku\u0161enosti s prov\u00E1d\u011Bn\u00EDm PET/CT s fluorocholinem (18F-FCH-PET/CT) u karcinomu prostaty. Metodika: Byla provedena anal\u00FDza indikac\u00ED a v\u00FDsledk\u016F 172 vy\u0161et\u0159en\u00ED 18F-FCH-PET/CT u 139 mu\u017E\u016F, pr\u016Fm\u011Brn\u00FD v\u011Bk nemocn\u00FDch byl 62,5 v rozp\u011Bt\u00ED 48-81 let. V\u011Bnovali jsme se v\u00FDskytu metast\u00E1z, vztahu hladiny PSA u biochemick\u00E9ho relaps a p\u0159\u00EDtomnosti n\u00E1dorov\u00E9 tk\u00E1n\u011B po radik\u00E1ln\u00ED l\u00E9\u010Db\u011B a tak\u00E9 porovn\u00E1n\u00ED bioptick\u00E9ho n\u00E1lezu s n\u00E1lezem PET/CT. V\u00FDsledky: U nemocn\u00FDch s hladinou PSA 2-5 ng/l jsme nalezli metast\u00E1zy nebo lok\u00E1ln\u00ED rekurenci v 77,4 %, u hladin nad 5 ng/l ve 100 %. P\u0159i porovn\u00E1n\u00ED n\u00E1lez\u016F biopsie s n\u00E1lezy PET/CT jsme dos\u00E1hli senzitivity 96 %, specificity 83,3 %. Z\u00E1v\u011Br: 18F-FCH-PET/CT je, jak ukazuj\u00ED na\u0161e v\u00FDsledky, efektivn\u00EDm n\u00E1strojem v posuzov\u00E1n\u00ED stagingu i restagingu karcinomu prostaty."@cs . . "Ferda, Ji\u0159\u00ED" . "PSA; PET/CT; fluorocholine; prostatic carcinoma"@en . "http://www.cesradiol.cz/dwnld/CesRad_1401_22_29.pdf" . "PET/CT s 18F-fluorocholinem u karcinomu prostaty, dvoulet\u00E9 zku\u0161enosti" . . . "Hora, Milan" . . "PET/CT s 18F-fluorocholinem u karcinomu prostaty, dvoulet\u00E9 zku\u0161enosti"@cs . . "F\u00EDnek, Jind\u0159ich" . "Ferdov\u00E1, Eva" . "Aim: To evaluate our own experience with fluorocholine 18F-FCH-PET/CT in prostatic carcinoma. Method: the analysis of the indications was performed in sample of 172 18F-FCH-PET/CT in 139 male patients, with mean age of 62.5 years in range 48-81 years. We evaluated number and site of metastases, the relation of PSA level in biochemical relaps with the presence of FCH accumulation in tumorous tissue and finally we correlate the findings of biopsy with results of PET/CT. Results: IN patients with PSA level 2-5 ng/1 we found in cases of biochemical relapse the accumulating tumorous tissue of local recurrence or metastases in 77.4%, in those patients with PSA level above 5 ng/1 in 100% of cases. In comparison of biopsies with PET/CT we found sensitivity 96% and specificity 83.3%. Conclusion: 18F-FCH-PET/CT is a valuable tool in evaluation of staging or restaging in patients with prostatic carcinoma."@en . "8"^^ . . . . "[EC9153F5BD3F]" . "\u010Cesk\u00E1 radiologie" . . "RIV/00216208:11140/14:10218527!RIV15-MSM-11140___" . . "C\u00EDl: Posoudit vlastn\u00ED zku\u0161enosti s prov\u00E1d\u011Bn\u00EDm PET/CT s fluorocholinem (18F-FCH-PET/CT) u karcinomu prostaty. Metodika: Byla provedena anal\u00FDza indikac\u00ED a v\u00FDsledk\u016F 172 vy\u0161et\u0159en\u00ED 18F-FCH-PET/CT u 139 mu\u017E\u016F, pr\u016Fm\u011Brn\u00FD v\u011Bk nemocn\u00FDch byl 62,5 v rozp\u011Bt\u00ED 48-81 let. V\u011Bnovali jsme se v\u00FDskytu metast\u00E1z, vztahu hladiny PSA u biochemick\u00E9ho relaps a p\u0159\u00EDtomnosti n\u00E1dorov\u00E9 tk\u00E1n\u011B po radik\u00E1ln\u00ED l\u00E9\u010Db\u011B a tak\u00E9 porovn\u00E1n\u00ED bioptick\u00E9ho n\u00E1lezu s n\u00E1lezem PET/CT. V\u00FDsledky: U nemocn\u00FDch s hladinou PSA 2-5 ng/l jsme nalezli metast\u00E1zy nebo lok\u00E1ln\u00ED rekurenci v 77,4 %, u hladin nad 5 ng/l ve 100 %. P\u0159i porovn\u00E1n\u00ED n\u00E1lez\u016F biopsie s n\u00E1lezy PET/CT jsme dos\u00E1hli senzitivity 96 %, specificity 83,3 %. Z\u00E1v\u011Br: 18F-FCH-PET/CT je, jak ukazuj\u00ED na\u0161e v\u00FDsledky, efektivn\u00EDm n\u00E1strojem v posuzov\u00E1n\u00ED stagingu i restagingu karcinomu prostaty." . "RIV/00216208:11140/14:10218527" . . "1" . "Hes, Ond\u0159ej" . . . "5"^^ . . "PET/CT with 18F-fluorocholine in prostatic carcinoma, two years experience"@en . "PET/CT with 18F-fluorocholine in prostatic carcinoma, two years experience"@en . "68" . "PET/CT s 18F-fluorocholinem u karcinomu prostaty, dvoulet\u00E9 zku\u0161enosti" . . . "I" . "Baxa, Jan" . . "11140" . "1210-7883" . "36333" . "CZ - \u010Cesk\u00E1 republika" . "6"^^ . "PET/CT s 18F-fluorocholinem u karcinomu prostaty, dvoulet\u00E9 zku\u0161enosti"@cs . . .